Standard regimen works as well as newer drug for athritis

06/12/2013 | HealthDay News

An older, cheaper regimen that combines methotrexate, sulfasalazine and hydroxychloroquine is as effective as the costlier combination of methotrexate and etanercept in treating rheumatoid arthritis patients who don't respond to methotrexate alone, a study found. U.S. researchers followed 353 patients and found no difference in improvements between the two groups. The study appeared online in the New England Journal of Medicine.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA